Summary. Serum phospholipid constituents in a selected group of hyperlipaemic diabetic patients with late manifestations have been investigated. In these patients the concentrations of serum lecithin as well as the eephalin fraction were increased. The absolute and relative increase of the cephalin fraction amounted to 3--4 times. It is indicated that the disturbances in serum phospholipids are due to insufficient metabolic control in these patients. The possible significance of the increase of serum cephalin for the occurrence of vascular complications is discussed.
serum.
The relationship between an elevation of phospholipids in plasma and the incidence of vascular diseases has captured attention in recent years. Special emphasis has been given to the increase in the cephalin fraction in patients with coronary heart disease and hyperlipaemia [15] .
Very little is yet known about the distribution and behaviour of the different phospholipids in the blood of diabetic patients with vascular complications. The aim of the present work, therefore, has been to investigate the total and the individual phospholipids in a selected group of diabetic patients with late manifestations. Since evidence has been obtained that the surface charge of the phospholipids is a most important factor in the process of blood coagulation [10] , special emphasis has been given to the determination, not only of the total concentrations of the individual phospholipids, but to the relative distribution, especially of lecithin and cephalins, as separated and quantitated by thin layer chromatography. The patients were selected according to investigations on lipoprotein pattern by paper electrophoresis, and determinations of the concentrations of total cholesterol and triglycerides.
Materials and Methods
The group of diabetic patients described in the present communication were all under observation in the University Clinic, RikshospitMet, Department of Medicine B, Oslo. They were selected being all of the juvenile type treated with insulin. A case report is given for each patient.
Case I. K.B.f. Age 58 y. Age at the onset of diabetes: 25 y. Duration of illness: 33 y. Weight: 90 kg, Height: 162 cm. The diabetes was badly regulated, and insulin 'feelings' frequently occured. A diabetic retinopathy with impaired vision in both eyes was present. The blood pressure was 260/140, being treated with methyldopa. No cardiac murmurs were heard and ictus cordis was not laterally displaced. Proteinuria and tibial oedema were found. However, the concentration of blood urea and creatinine were within normal limits. ]n addition, a slight diabetic neuropathy with lowered tendon reflexes and sensibility was demonstrated. The blood serum showed no opalescence, and the lipoprotein lipase activity was considered normal. In Table 1 the patients are presented individually with special emphasis on the duration of illness and the state of complications. The metabolic control of the patients was based upon diurnal blood sugar levels, excretion of urinary sugar, changes in insulin requirement and general clinical evaluation during some weeks preceeding the examination of serum lipids. A satisfactory metabolie control had not been achieved in these patients except Case V (L.N.). It is seen that retinopathy was most common among late manifestations in this group of patients.
Blood sampling. The blood samples were collected after 14 h of fasting without use of anticoagulant. The samples were allowed to coagulate, chilled and centrifuged at 4~ for 10 min at 2000 r.p.m. After immediate separation the scra were kept in the cold and protected from light to avoid autoxidation, which can give an unspecific increase in the lysophospholipid compounds. The sera were investigated on the day of sampling.
Lipid extraction. A serum lipid extract was prepared according to Svennerholm 1. Conical tubes with glass stoppers were used for the extraetion procedure. To 6 ml chloroform-methanol mixture (1:1, v/v) was added 0.5 ml serum drop~gse with vigorous shaking on a Vortex mixer. The samples were left at room temperature for 30 rain for complete precipitation of the proteins. The precipitate was packed by centrifugation at 2500 r.p.m, for 10 rain. The supernatant fluid was transferred to a second conical tube, the precipitate was washed with 2 ml chloroform-methanol (1 : 1, v/v) and the washing added to the supernatant fluid. Thereupon, 4 ml chloroform and 2 ml acid-salt solution (0.1% NaCl~-0.002 N H2SOt) were added, and a vigorous shaking was performed for the phase separation. After centrifugation for 10 min at 2500 r. p.m., the upper aqueous-methanol phase was removed with a Pasteur pipette and suction. The walls of the tube and the surface of the chloroform layer were washed twice by the careful addition of 1 ml washing reagent (prepared by mixing 15 ml chloroform, 260 ml methanol and 250 ml 0.1% NaC1), which was removed by suction. The lower chloroform phase was transferred to a 10 ml cylinder, and adjusted to the mark with methanol. This serum-lipid extract was kept at --18 ~ in the dark before use. Aliquots were taken for evaporation to dryness under nitrogen in a waterbath at 40 --50 ~ C, protected from light.
Thin layer chromatography. Chromatography was performed on glass plates (200 • 200 mm), covered with silica gel G (E. Merck AG, Darmstadt, Germany). A slurry was made by mixing 40 g of silica gel G with 90 ml water for neutral plates or 90 ml of 0.005 M Na~ i personal communication
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C03-solution for basic plates. The slurry was transferred to the applicator and applied on the plates as a layer of 0.5 mm thickness. The plates were allowed to dry at room temperature for 1--2 h, and were stored in a cabinet without drying agent. Before the experiment the plates were activated at 110~ for 1 h.
The dried lipid extracts were redissolved in an ap, propriate volume 25-50 ~1 chloroform, and applied along a line 1.5 cm long with standardized micropipettes. Additional 25 ~1 chloroform was used to wash the tubes and this volume was applied on the same line. Routinely, 5 ml of the serum-lipid extract was evaporated for each application for the determination of lysolecithin 2, sphingomyelin and eephalin. For convenience, the quantitative determination of the lecithin spot was performed by evaporating 1 ml serum-lipid extract and was run on separate plates. Triplicates were run from each serum. Up to three serum-lipid extracts were Table 1 . Characterization follows : After moistening with a drop of water the spot could be scraped off and transferred to a Pyrex tube for ashing. A complete transfer was obtained by the use of a fitted spatula. Blanks from powder were cut from parts of the gel where no lipids had been applied. No phosphorus was found in these spots. The determination of total lipid P in serum was done on 1 ml serumlipid extract (corresponding to 0.05 ml serum).
Phosphorus determination. The quantitative determination of the phospholipid samples was done essentially according to the method of Bartlett [2] . The digestion was performed in calibrated Pyrex tubes with 0.5 ml 10 N II2SO t. The ashing procedure was performed in a sand-bath at 180 ~ to 230~ for 1 89 h. After cooling, three drops of H~O 2 were added, and the tubes reheated for 15 minutes. Thereupon the walls were washed with 0.4 ml water and the solution boiled for 15 rain. Then 3.0 ml water, 0.4ml 2.5 per cent ammoniof the diabetic patients Age  59  44  42  29  55  25  Type  juvenile  juvenile  juvenile  juvenile  juvenile  juvenile  Duration of 
prepared from each serum sample and pooled before the aliquots were taken for evaporation. Reference compounds s, each corresponding to 3--4 txg phosphorus were dissolved in chloroform and applied on the plate, in addition to the three lines with extracts. One dimensional chromatograms were routinely developed with chloroform-methanol-water (65 : 25 : 4 by volume). Additional runs were done according to Skipski et al. [21] in chloroform-methanol-glacial acetic acid-water (25:15:4:2). The running time was 1--1~ h (12 cm from the application spot). The plates were air dried at room temperature for 30 rain. The spots were detected with iodine vapour and encircled with a needle. According to the amount applied no spot exceeded 1. Koch-Light 38406.
um molybdate and 0.2 ml Fiske-SubbaRow's reagent were added and the sample diluted to the 5 ml mark. The reagents were mixed and heated for 7 rain in a boiling water bath. After colour development the silica gel was removed by centrifugation at 2500 r.p.m, for 10 rain. Optical density was read at 830 m F. An 0D reading of 0.12 was given by 1 ~g P (KH~P04). Recovery of lecithin standard from the plate was 99 per cent, of the cephalin fraction (phosphatidylethanolamine ~-phosphatidylserine) was 90 per cent. The average recovery for the serum lipid extracts amounted to 91.5 per cent, which is in good agreement with the recoveries given by Gjone and Orning [7] . The serum triglycerides were determined according to Laurell [12] . The serum cholesterol was determined by the method of Carr and Drekter [4] . Lipoprotein paper electrophoresis in albumin-containing buffer was performed according to Lees and Hatch [13] .
Comments on the method. Determination of the individual phospholipids in serum under normal and pathological conditions requires careful analytical precautions to avoid nonspecific variations in the concentration of the compounds.
Blood sampling. As discussed by Vikrot [22] , phospholipids may be liberated from the blood cells during coagulation, especially from the platelets, and bound to the clot 9 In the present work a substantial coagulation was present before chilling and no haemolysis occured. No counting of plate]ets was performed 9 In heparinized plasma Gjone et al. [6] found no difference in the concentration of the individual lipids compared with the values found in serum [7] . By counting the platelets [7] in heparinized plasma and citrated plasma the number of platelets did not influence the concentration of lysolecithin, lecithin and sphingomyelin, and only a slight increase in the cephalin fraction could be observed 9 The standardized procedure for blood sampling used in the present work, therefore, excludes the possibility that differences in cephalin fraction could depend upon the technique of blood sampling.
Extraction procedure. In the present work the 10re- Individual serum phospholipids in diabetics. The level of total phospholipids and the distribution of individual phosphotipid components in sera h'om the diabetic patients are shown in Table 3 . Five of these patients had an elevated level of total phospholipids, the highest value being 321 mg/100 ml (range of control group 175--202 mg/100 ml). This increase of total phospholipids in the diabetics was somewhat different from the control group. The marked increase in the cephalin fraction is reflected in a higher percentage of this group compared with the controls (mean values of diabetics 12 per cent against 4 per cent in normals). Correspondingly, the percentage distribution of lecithin is somewhat decreased (mean values in diabetics 60 per cent against 72 per cent in normals).
Determination of other lipid constituents in, sera of the diabetics, The values of serum cholesterol, serum triglycerides as well as the lipoprotein pattern in the diabetic patients are also presented ( Table 4) . Four of the patients revealed some abnormalities. These patients phospholipids was mainly due to an increase in the lecithin and in the cephalin fraction. The lecithin fraction was increased in four patients, the highest value being 206 mg/100 ml (range in controls 120--150 rag/ 100 ml). The eephalin fraction showed a marked increase in five of these patients, the mean value being increased 4--5 times compared with the controls. The highest value was 55 mg/100 ml compared with a range of 4--14 rag/100 ml in controls.
A slight increase in the Iysoleeithin fraction was observed in most of the patients, an observation which needs more extensive investigation. The level of sphingomyclin in serum was not significantly increased in this group of diabetics.
The percentage distribution of the individual (described in case reports as I, II, III, IV) showed a lipoprotein pattern consistent with a hyperlipaemia Type II according to the classification of Fredrickson et al. [5] . These four patients had a cholesterol level in serum ranging from 330--440 mg per 100 ml. Patient Ir H. (case report III) had also a pronounced elevated pre-beta-lipoprotein fraction. The classification of this patient will therefore be consistent also with a Type III pattern. The decision whether this patient belongs to Type II, III or IV cannot be made by simple electrophoresis and routine lipid determinations, but must be confirmed by ultracentrifugation of serum and immunological investigation as discussed by Seidel et al. [20] . The two remaining patients showed normal distribu. tion of these lipid constituents,
Discussion
The statement made by Fredrickson [5] that hyperbeta-lipoproteinaemia of Type II is a major causal factor in the accelerated atherosclerotic vascular disease seems well documented by many authors. In man the beta-lipoproteins are the main cholesterol and phospholipid bearing proteins. The correlation between coronary heart disease and phospholipids has been established by Nothman and Proger [15] . Their group of patients showed, in addition to hypercholesterolaemia, an increase in total phospholipids in platelet-poor plasma. An increase in the eephalin fraction was found, which amounted to 2--3 times the values found in normal controls. The cephalin fraction was also increased compared with normals when expressed as percentage of total phospholipids. Therefore these authors have called attention to the importance of this increase in the eephalin fraction in blood where arterial occlusion is present.
In the present communication the selected group of diabetic patients has shown an increase in total phospholipids, and an absolute and relative increase in the cephalin fraction. It is tempting to assume that lipoprotein particles, especially of the beta-lipoprotein type, which are rich in phospholipids, can contribute cephalins of importance for the coagulation process in blood. Several observations are in line with this hypothesis. Thus O'Brien [16] has found that phosphatidylethanolamine could substitute for platelets in the thrombin generation test, and Stypven clotting time, whereas lecithin was almost completely inactive in the coagulation of human plasma poor in platelets. Chylomicrons have been used as a source of cephalin in thrombin generation test [18] , and shortening of clotting time can be observed under alimentary lipaemia. If, as suggested by Poole [17] , FFA in blood also can contribute to the shortening of the clotting time, at least part of this effect can be attributed to the lipoprotein particles produced in the liver in response to FFA. Kline [11] has pointed out that even liver mierosomes can have pro-coagulant activity, which when liberated to the blood can induce prothrombin activity.
The mechanism of liberation of eephMin into the blood or in the blood is poorly understood. The release of phospholipids may be related to the action of ADP [3] , which is known to bring about an adhesion and aggregation of platelets [8] . Such a mechanism may be operating in disease where increase in the concentration of the cephalins in the blood is observed. Since the present work has shown an increase in total phospholipids with a relative increase in the cephalin fraction, the methylating capacity of the liver and the fat secretion mechanism are most likely disturbed under the pathological conditions described.
An important problem is whether or not the abnormalities in serum phospholipids are of primary significance for the late complications in diabetes. In studies published elsewhere [25] we have observed that diabetic patients under good clinical control have normal serum lipoprotein levels including those patients who had developed late manifestations. There was no relationship between the level of pre-betalipoproteins and diabetic retinopathy or neuropathy. gyperlipoproteinaemia was present only in juvenile diabetics with ketoacidosis. The concept that hyperlipoproteinaemia in diabetics is related to poor control of the disease is supported by this and other investigations [1, 9, 19] . In agreement with these authors, we have not observed hyperlipoproteinaemia or an increase in serum eephalin or lecithin in maturity-onset diabetics in which there was good clinical control (unpublished observations). As mentioned previously, an appropriate metabolic control of the diabetic patients reported in the present study had not been achieved. Our investigations, therefore, indicate that the abnormalities in serum lipid constituents which have been observed occur as a secondary consequence of the diabetic metabolic disturbances.
It should be pointed out that increased serum cephalin is not a common finding in non-diabetic patients with hyperlipoproteinaemia. In such patients Vikrot et al. [23] and Wille and Phillips [26] observed disturbances in the sphingomyelin/lecithin ratio but no increase in serum cephalin.
In conclusion, this study indicates that hyperlipoproteinaemia with an absolute and relative increase in serum cephalin occurs as a consequence of insufficient metabolic control in diabetic patients. Although our evidence indicates that these disturbances do not cause the late-developing manifestations of diabetes, these may be exaggarated when the serum eephalin level is increased.
